A Novel High Resolution In Vivo Digital Imaging System for the Evaluation of Experimental Cataract in Diabetic Rats

  • Kametaka Sokichi
    Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, Japan
  • Kasahara Takafumi
    Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, Japan
  • Ueo Mayumi
    Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, Japan
  • Takenaka Mariko
    Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, Japan
  • Saito Maki
    Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, Japan
  • Sakamoto Kenji
    Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, Japan
  • Nakahara Tsutomu
    Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, Japan
  • Ishii Kunio
    Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, Japan

この論文をさがす

抄録

The purpose of this study was to establish a novel imaging system for evaluation of cataract in small animals. Diabetic cataract was induced in male Wistar rats by a combination of a bolus injection of streptozotocin (65 mg/kg, i.v.) and 5% D-glucose given as drinking water. To assess cataract development, we designed a digital camera system equipped with a non-reflecting illuminator for capturing clear high-resolution full lens images in the horizontal plane. Cataract was evaluated from the resulting images using both an observer-based scoring system and quantitative digital image-analysis techniques. The onset of cataract was detected in the peripheral section of the lens in 57% of cases 2 weeks after induction of hyperglycemia. Central opacities were visible following 3 weeks in hyperglycemic conditions. The cataract increased in severity with time, so that by week 9 in hyperglycemic conditions, mature cataracts were developed in over 90% of lenses. Treatment of diabetic rats with GP-1447, an aldose reductase inhibitor, completely prevented the formation of diabetic cataracts. These results indicate that the digital imaging system established in the present study permits an assessment of all stages of cataract development and it is helpful for accurately evaluating the effects of therapeutic drugs on cataracts.<br>

収録刊行物

被引用文献 (8)*注記

もっと見る

参考文献 (41)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ